太平洋生物科学公司（Pacific Biosciences of California，股票代码：PACB）今日盘后股价大幅下跌，引发投资者关注。据悉，该公司股价在盘后交易中暴跌6.01%，显示出投资者对公司最新财报的负面反应。
太平洋生物科学公司于今日发布了2025年第三季度财报。报告显示，公司第三季度经调整后的毛利润为1620万美元，每股收益为-0.13美元。这一业绩数据显示公司仍处于亏损状态，可能未能达到市场预期。
分析人士指出，公司持续亏损的状况可能是导致股价大跌的主要原因。尽管公司实现了1620万美元的调整后毛利润，但负的每股收益表明公司在盈利能力方面仍面临挑战。投资者可能对公司的财务状况和未来增长前景产生了担忧，从而引发了这波抛售潮。后市走势如何，还需进一步观察公司的业务发展和市场反应。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.